LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 89.57 | 84.90 | 1173 | 7494 | 0.1565 | 0.5012 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 89.57 | 84.90 | 1 | 7494 | 0.0001 | -0.4970 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 89.57 | 84.90 | 6 | 7494 | 0.0008 | -0.3363 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 91.27 | 84.90 | 54 | 7420 | 0.0073 | -0.0677 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 91.27 | 84.90 | 1162 | 7420 | 0.1566 | 0.5003 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 91.27 | 84.90 | 1 | 7420 | 0.0001 | -0.4977 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 91.27 | 84.90 | 7 | 7420 | 0.0009 | -0.3209 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 92.98 | 84.90 | 56 | 7257 | 0.0077 | -0.0628 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 92.98 | 84.90 | 1228 | 7257 | 0.1692 | 0.5164 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 92.98 | 84.90 | 1 | 7257 | 0.0001 | -0.4995 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 92.98 | 84.90 | 5 | 7257 | 0.0007 | -0.3568 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 94.68 | 84.90 | 64 | 7000 | 0.0091 | -0.0434 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 94.68 | 84.90 | 1263 | 7000 | 0.1804 | 0.5283 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 94.68 | 84.90 | 1 | 7000 | 0.0001 | -0.5023 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 94.68 | 84.90 | 5 | 7000 | 0.0007 | -0.3591 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 2.66 | 84.90 | 2 | 285 | 0.0070 | -0.8824 | MN20160318_Q02 | D21 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 2.66 | 84.90 | 590 | 285 | 2.0648 | 2.0260 | MN20160318_Q02 | D21 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | L20 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 2.66 | 84.90 | 617 | 285 | 2.1593 | 2.1043 | MN20160318_Q02 | L20 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 4.36 | 84.90 | 2 | 322 | 0.0062 | -0.8572 | MN20160318_Q02 | D21 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 4.36 | 84.90 | 678 | 322 | 2.1019 | 1.9413 | MN20160318_Q02 | D21 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | L20 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 4.36 | 84.90 | 709 | 322 | 2.1980 | 2.0104 | MN20160318_Q02 | L20 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | D21 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.0010833 | 6.06 | 84.90 | 769 | 365 | 2.1042 | 1.8474 | MN20160318_Q02 | D21 |